Rasmus Michael Sandsdal

✨ Thrilled and honored to have been awarded a PhD grant from Danish Diabetes and Endocrine Academy @DDEA_Denmark! 🧠 Thank you this opportunity to help advance the evolving field of #neuroendocrinology! #fmri #semaglutide

New study in Cardiovascular Diabetology @BioMedCentral shows that GLP-1 RA and #exercise can lower metabolic syndrome, abdominal #obesity, and #inflammation, potentially reducing the risk of future #CVD or #diabetes @BiomedUCPH @STorekov @RasmusSandsdal cardiab.biomedcentral.com/articles/10.11…

Our new study on improved sperm quality with sustained weight loss is out in Human Reproduction! @BiomedUCPH @UCPH_health academic.oup.com/humrep/advance…

Enjoying the time in Maastricht for the European Congress on #Obesity @EASOobesity #ECO2022

Spændende at være med i “Sygt nok” på P1 i samtale med ⁦@MajaThiele⁩ og ⁦@tunepers⁩ om hjernes betydning for vægttab dr.dk/radio/p1/sygt-…

Spændende samtale med Anders Nedergaard @dr_muskel i Fitness M/K om vores vægttabsforskning spreaker.com/user/anders_ne…

#NatMetabPicks | Recently published in @NEJM, a group led by @STorekov (@uni_copenhagen) find that combining the GLP1 agonist liraglutide with exercise promotes maintenance of weight loss and improvements in glycemia. nejm.org/doi/full/10.10…

What is the best way to maintain a weight loss? New exciting RCT from @STorekov proves that liraglutide in combination with #exercise is very effective. Collab w/ @AmagerHvidovre. Out now in @NEJM. Read more: healthsciences.ku.dk/newsfaculty-ne… #weightloss

In this trial, adults with obesity without diabetes were randomly assigned to 1 year of placebo, an exercise program, liraglutide, or exercise plus liraglutide. Combined treatment with exercise and liraglutide improved healthy weight loss maintenance.